NCT06176807

Prediction of Acute Kidney Injury in Patients With Sepsis Using Venous Excess Ultrasound Score

Status unknown Last updated 20 December 2023

What this trial tests

trial testing Venous Excess Ultrasound Score in Intensive Care Unit in 60 participants. Status unknown.

Timeline

1 September 2023

Primary endpoint
1 January 2024

30 January 2024

Quick facts

Lead sponsor	Mansoura University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	60
Start date	1 September 2023
Primary completion	1 January 2024
Estimated completion	30 January 2024
Sites	1 location across Egypt

Drugs / interventions tested

• Venous Excess Ultrasound Score

Conditions studied

• Intensive Care Unit — all drugs for Intensive Care Unit →

Sponsor

Mansoura University

Who can join

Adults 21 to 65, any sex, with Intensive Care Unit. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. Sepsis and septic shock are major healthcare problems, killing between one in three and one in six of those they affect. organ dysfunction can be represented by the Sequential Organ Failure Assessment (SOFA) score of 2 points or more (respiratory rate of 22/min or greater, altered mentation, or systolic blood pressure of 100 mm Hg or less), which is associated with an in- hospital mortality greater than 10%.

Septic shock is defined as a subset of sepsis in which profound circulatory, cellular, and metabolic abnormalities are associated with a greater risk of mortality than with sepsis alone. Patients with septic shock can be clinically identified by a vasopressor requirement to maintain a mean arterial pressure of 65 mm Hg or greater and serum lactate level greater than 2 mmol/L (\>18 mg/dL) in the absence of hypovolemia. This combination is associated with hospital mortality rates greater than 40%.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.